← Back to Search

Shock Wave Therapy

Shockwave Treatment for Connective Tissue Disorder

N/A
Waitlist Available
Research Sponsored by Cynosure, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days post treatment
Awards & highlights

Study Summary

This trialstudies a device to assess the effectiveness of shock wave treatment for medical purposes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days post treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days post treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
# of Subjects With Altered Gene Expression

Trial Design

1Treatment groups
Experimental Treatment
Group I: Shockwave DeviceExperimental Treatment1 Intervention
The Shockwave device will be used on multiple areas of the body for the purpose of treating connective tissue.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Shockwave Treatment
2021
N/A
~10

Find a Location

Who is running the clinical trial?

Cynosure, Inc.Lead Sponsor
51 Previous Clinical Trials
1,231 Total Patients Enrolled
Jennifer CiviokStudy DirectorCynosure, Inc.
16 Previous Clinical Trials
487 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Apr 2025